Answers are grounded in this paper and cite their sources.
Advancements in biomaterial science and available cell sources have spurred the translation of tissue-engineering technology to the bedside, addressing the pressing clinical demands for replacement cardiovascular tissues. Here, the in vivo status of tissue-engineered blood vessels, heart valves, and myocardium is briefly reviewed, illustrating progress toward a tissue-engineered heart for clinical use.
No takes yet. Share an insight, caveat, or question.
Best et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: